Novartis
AFINITOR
Manufacturer:
Novartis
Name:
AFINITOR
HCPCS Code Descriptor:
Everolimus, oral, 0.25 mg
Category:
J Code
HCPCS:
J7527
NDC(s):
00078-0414-20, 00078-0414-61, 00078-0415-20, 00078-0415-61, 00078-0417-20, 00078-0417-61, 00078-0422-20, 00078-0422-61, 00078-0566-51, 00078-0566-61, 00078-0567-51, 00078-0567-61, 00078-0594-51, 00078-0594-61, 00078-0620-51, 00078-0620-61, 00078-0626-51, 00078-0626-61, 00078-0627-51, 00078-0627-61, 00078-0628-51, 00078-0628-61, 67877-0721-31, 67877-0719-31, 67877-0720-31, 67877-0718-31, 00054-0470-21, 00054-0471-21, 00054-0472-21, 00054-0480-13, 00054-0480-14, 00054-0481-13, 00054-0481-14, 00054-0497-13, 00054-0497-14, 00054-0604-21, 49884-0160-02, 49884-0283-02
Primary Type:
Oncology
Generic Status:
Multi-Source
Route of Administration:
Oral
About:
AFINITOR is an Oncology drug manufactured by Novartis and administered via the Oral route of administration. The J Code: J7527 is aligned to the drug AFINITOR.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/13
HCPCS Effective Date:
1/1/14
HCPCS Short Description:
Oral everolimus
Billing and Coding Guide:
Not Found
Patient Assistance:
https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment
https://www.novartis.us/our-products/patient-assistance/patient-assistance-foundation-enrollment